Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, Non-Hodgkin × efavirenz × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 B-cell Tumors 1

Interventions

Cyclophosphamide 58 Rituximab 54 fludarabine 33 fludarabine phosphate 32 venetoclax 24 Filgrastim 22 Etoposide 18 Bendamustine Hydrochloride 18 Gemcitabine 17 Peripheral Blood Stem Cell Transplantation 15 Bortezomib 15 Melphalan 14 obinutuzumab 13 Lenalidomide 12 Dexamethasone 12 Cytarabine 12 Vincristine 11 Vorinostat 10 Tacrolimus 10 Azacitidine 10 pembrolizumab 9 Prednisone 9 Mycophenolic Acid 9 Doxorubicin 9 ibrutinib 8 copanlisib 8 Whole-Body Irradiation 8 Paclitaxel 8 Interleukin-2 8 Carmustine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed

25 enrolled 11 charts

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡